- Home
- KNSA vs WING Comparison
KNSA vs WING Comparison
Compare KNSA & WING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | WING |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.4B |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | KNSA | WING |
|---|---|---|
| Price | $77.19 | $103.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 27 |
| Target Price | $60.86 | ★ $295.92 |
| AVG Volume (30 Days) | 415.4K | ★ 1.1M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | ★ 225.00 | 67.84 |
| EPS | 0.27 | ★ 2.23 |
| Revenue | $677,564,000.00 | ★ $696,853,000.00 |
| Revenue This Year | $37.48 | $17.20 |
| Revenue Next Year | $17.87 | $15.86 |
| P/E Ratio | $293.81 | ★ $46.53 |
| Revenue Growth | ★ 60.09 | 11.35 |
| 52 Week Low | $35.33 | $100.13 |
| 52 Week High | $82.94 | $302.80 |
Technical Indicators
Market Signals| Indicator | KNSA | WING |
|---|---|---|
| Relative Strength Index (RSI) | 54.16 | 39.54 |
| Support Level | $44.95 | N/A |
| Resistance Level | $81.97 | $119.43 |
| Average True Range (ATR) | 2.39 | 6.56 |
| MACD | -0.39 | 0.01 |
| Stochastic Oscillator | 56.80 | 21.37 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About WING Wingstop Inc.
Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.